Siemens Healthineers Receives FDA Clearance for Blood Urea Nitrogen and Total CO<sub>2</sub> Point-of-Care Testing

Testing at the point-of-care improves patient care with results in less than a minute

18 Feb 2018
Lui Terry
Administrator / Office Personnel

Industry news

Siemens Healthineers has announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Blood Urea Nitrogen (BUN) and Total Carbon Dioxide (TCO2) point-of-care tests to aid in the diagnosis of renal diseases and metabolic imbalances. These assays expand precision medicine performed at the patient-side to enable faster clinical decision making.

In its continued effort to improve patient care, Siemens Healthineers now can provide a full menu on a single test card within the blood analysis market for clinicians to perform at the patient bedside on the handheld epoc® Blood Analysis System. A broad menu benefits clinical service lines that routinely perform blood analysis, including critical care units, the emergency department, radiology, cardiac catheterization labs and out-patient centers.

“With the epoc system, these new assays will expand the patient information clinicians can access sooner to help rule in or rule out potential diagnoses more quickly,” said Michael Sampson, Senior Vice President, Point of Care Diagnostics, North America, Siemens Healthineers. “Rapid, informed diagnoses and treatment decisions at the patient-side ultimately aids in improving clinical outcomes.”

BUN—combined with creatinine and an estimated glomular filtration rate (eGFR)—also available on the epoc system—can aid in the differential diagnosis of renal and metabolic diseases. TCO2—with other parameters that comprise a basic metabolic panel currently available at the point of care from Siemens Healthineers—can aid clinicians in assessing acid base and metabolic imbalances and make changes in therapy where necessary.

The epoc® Blood Analysis System delivers a full menu of results, including pH, partial pressure of oxygen, partial pressure of carbon dioxide, sodium, potassium, ionized calcium, hematocrit, glucose, lactate, creatinine, chloride, and soon BUN and TCO2, in less than a minute. Results are easily integrated into any Laboratory Information System.


Links

Tags

Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.Point of Care SolutionsPoint of care solutions provide medical diagnostics and treatments at or near the site of patient care. These technologies offer rapid results, helping healthcare providers make quick decisions. From glucose monitors to molecular diagnostics, point of care solutions are transforming healthcare delivery by reducing wait times and improving patient outcomes. Explore the best point of care products in our peer-reviewed product directory, compare options, check reviews, and get pricing directly from manufacturers.
Siemens Healthineers Receives FDA Clearance for Blood Urea Nitrogen and Total CO<sub>2</sub> Point-of-Care Testing